Understand industries, connect industries

17.01.2017 | Dr. Verena Grimm joined the BioRegio STERN Management GmbH team as a project manager in January 2017. The biotechnologist completed a tri-national degree course in Germany, Switzerland and ...

Amgen and immatics enter strategic collaboration to develop novel bispecific cancer immunotherapies

09.01.2017 | Arrangement Combines Immatics’ XPRESIDENT® Technology and Amgen’s Proprietary Bispecific Antibody Platform. Immatics to ...

Study with CureVac’s RNAdjuvant® Technology Published in Cancer Immunology, Immunotherapy

06.12.2016 | For the first time, evidence suggests the same vaccine formulation (RNAdjuvant®) may elicit similar potency in both cancer patients and ...

CureVac Secures an Additional $29.5 Million From Two New Investors

08.11.2016 | Baden-Württembergische Versorgungsanstalt für Ärzte, Zahnärzte und Tierärzte and Landeskreditbank Baden-Württemberg invest in CureVac‘s development of ...